EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Clinical trials for EXUDATIVE AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
App aims to reduce eye injection visits for macular degeneration
Disease control Not yet recruitingThis study is testing whether a smartphone app can help people with wet age-related macular degeneration (AMD) safely go longer between their regular eye injections. 80 participants already receiving Aflibercept 8 mg injections will use the app at home to monitor their vision for…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Higher-Dose eye shot aims to cut down treatment visits for common vision loss
Disease control Not yet recruitingThis study is looking back at medical records to see if switching patients with a severe form of wet age-related macular degeneration (AMD) to a new, higher-dose version of an existing eye injection (aflibercept 8 mg) helps. The main goal is to see if patients can go longer betwe…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
AI steps into the eye Doctor's office
Disease control Not yet recruitingThis study is testing a new AI tool designed to help eye doctors decide the best timing for anti-VEGF injections. These injections treat 'wet' macular degeneration and similar conditions that cause fluid leaks in the back of the eye. The AI analyzes eye scans and patient informat…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC